{"id":3177,"date":"2024-03-10T21:28:16","date_gmt":"2024-03-10T20:28:16","guid":{"rendered":"https:\/\/solmed-clinic.com\/?post_type=ispitivanja&p=3177"},"modified":"2024-07-01T20:50:25","modified_gmt":"2024-07-01T18:50:25","slug":"ulcerative-colitis-vedolizumab-study","status":"publish","type":"ispitivanja","link":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/","title":{"rendered":"Ulcerative Colitis (Vedolizumab Study)"},"content":{"rendered":"

Location: Solmed Polyclinic (Zagreb)<\/h3>\n

Study Drug:<\/strong> Patients will receive standard biological therapy with vedolizumab or vedolizumab biosimilar.<\/p>\n

Main Inclusion Criteria:<\/strong> Patients aged 18 and older with an official diagnosis of ulcerative colitis who, with at least one previous line of treatment (either conventional or biological therapy), have symptoms of active disease.<\/p>\n

Status: In preparation<\/span><\/h3>\n

Start of patient enrollment: September 2024<\/p>\n

Planned completion of patient enrollment: June 2025<\/p>\n","protected":false},"excerpt":{"rendered":"

Study Drug: Patients will receive standard biological therapy with vedolizumab or vedolizumab biosimilar.<\/p>\n","protected":false},"featured_media":0,"template":"","status_ispitivanja":[81,6],"podrucja":[116],"class_list":["post-3177","ispitivanja","type-ispitivanja","status-publish","hentry","status_ispitivanja-includes-patients","status_ispitivanja-ukljucuje-pacijente","podrucja-gastroenterology"],"acf":[],"yoast_head":"\nUlcerative Colitis (Vedolizumab Study) - Solmed Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ulcerative Colitis (Vedolizumab Study) - Solmed Clinic\" \/>\n<meta property=\"og:description\" content=\"Study Drug: Patients will receive standard biological therapy with vedolizumab or vedolizumab biosimilar.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Solmed Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/solmedgrupa\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-01T18:50:25+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/\",\"url\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/\",\"name\":\"Ulcerative Colitis (Vedolizumab Study) - Solmed Clinic\",\"isPartOf\":{\"@id\":\"https:\/\/solmed-clinic.com\/#website\"},\"datePublished\":\"2024-03-10T20:28:16+00:00\",\"dateModified\":\"2024-07-01T18:50:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Po\u010detna stranica\",\"item\":\"https:\/\/solmed-clinic.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ulcerative Colitis (Vedolizumab Study)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/solmed-clinic.com\/#website\",\"url\":\"https:\/\/solmed-clinic.com\/\",\"name\":\"Solmed Clinic\",\"description\":\"Solutions in medicine\",\"publisher\":{\"@id\":\"https:\/\/solmed-clinic.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/solmed-clinic.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/solmed-clinic.com\/#organization\",\"name\":\"Solmed Clinic\",\"url\":\"https:\/\/solmed-clinic.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg\",\"contentUrl\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg\",\"width\":482,\"height\":77,\"caption\":\"Solmed Clinic\"},\"image\":{\"@id\":\"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/solmedgrupa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ulcerative Colitis (Vedolizumab Study) - Solmed Clinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/","og_locale":"en_US","og_type":"article","og_title":"Ulcerative Colitis (Vedolizumab Study) - Solmed Clinic","og_description":"Study Drug: Patients will receive standard biological therapy with vedolizumab or vedolizumab biosimilar.","og_url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/","og_site_name":"Solmed Clinic","article_publisher":"https:\/\/www.facebook.com\/solmedgrupa","article_modified_time":"2024-07-01T18:50:25+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/","url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/","name":"Ulcerative Colitis (Vedolizumab Study) - Solmed Clinic","isPartOf":{"@id":"https:\/\/solmed-clinic.com\/#website"},"datePublished":"2024-03-10T20:28:16+00:00","dateModified":"2024-07-01T18:50:25+00:00","breadcrumb":{"@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/ulcerative-colitis-vedolizumab-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Po\u010detna stranica","item":"https:\/\/solmed-clinic.com\/en\/"},{"@type":"ListItem","position":2,"name":"Ulcerative Colitis (Vedolizumab Study)"}]},{"@type":"WebSite","@id":"https:\/\/solmed-clinic.com\/#website","url":"https:\/\/solmed-clinic.com\/","name":"Solmed Clinic","description":"Solutions in medicine","publisher":{"@id":"https:\/\/solmed-clinic.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/solmed-clinic.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/solmed-clinic.com\/#organization","name":"Solmed Clinic","url":"https:\/\/solmed-clinic.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/","url":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","contentUrl":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","width":482,"height":77,"caption":"Solmed Clinic"},"image":{"@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/solmedgrupa"]}]}},"_links":{"self":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/3177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja"}],"about":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/types\/ispitivanja"}],"version-history":[{"count":4,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/3177\/revisions"}],"predecessor-version":[{"id":3879,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/3177\/revisions\/3879"}],"wp:attachment":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/media?parent=3177"}],"wp:term":[{"taxonomy":"status_ispitivanja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/status_ispitivanja?post=3177"},{"taxonomy":"podrucja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/podrucja?post=3177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}